Débora Rosa Bublik

1.0k citations
14 papers · 807 indexed · h-index 12
Topics
MicroRNA in disease regulation (5 papers)RNA Research and Splicing (4 papers)RNA modifications and cancer (3 papers)
Partner nations
IsraelItalyCroatia

In The Last Decade

Débora Rosa Bublik

13 papers receiving 801 citations

Peers

Débora Rosa Bublik
Comparison fields: 5 of 76
  • Molecular Biology 660
  • Cancer Research 257
  • Immunology 165
  • Oncology 150
  • Surgery 53
Replace Yanhui Yin with:
Yanhui Yin China
Annika Hau United States
Dorine Bellanger France
Hongxing Shen United States
James R. Hernandez United States
Xiaoyi Mi China
Sui-Sui Dong China
Shuet Theng Lee Singapore
Yi Sang China
Ross S. Thomas Australia
Débora Rosa Bublik relative to Yanhui Yin China Yanhui Yin's profile →
Citations per field
00.5×1.5×2.0×
Yanhui Yin · 1×
Citations per year

Countries citing papers authored by Débora Rosa Bublik

Since Specialization
Citations

This map shows the geographic impact of Débora Rosa Bublik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Débora Rosa Bublik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Débora Rosa Bublik more than expected).

Fields of papers citing papers by Débora Rosa Bublik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Débora Rosa Bublik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Débora Rosa Bublik. The network helps show where Débora Rosa Bublik may publish in the future.

Co-authorship network of co-authors of Débora Rosa Bublik

This figure shows the co-authorship network connecting the top 25 collaborators of Débora Rosa Bublik. A scholar is included among the top collaborators of Débora Rosa Bublik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Débora Rosa Bublik. Débora Rosa Bublik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 0
2 35
3 26
4 69
5 55
6 61
7 79
8 33
9 48
10 6
11 100
12 35
13 206
14 54

About Débora Rosa Bublik

Débora Rosa Bublik is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 14 papers that have together received 807 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), RNA Research and Splicing (4 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (257 citations), Molecular Biology (660 citations) and Immunology (165 citations). Débora Rosa Bublik has collaborated with scholars based in Israel, Italy and Croatia. Frequent co-authors include Moshe Oren, Claudio Schneider, Martín Monte, Yitzhak Pilpel, Leticia Y. Peche, Marco A. Pierotti, Marta Simonatto, Monica Rodolfo, Stefania Gobessi and Sylvia Wilder. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026